SYRE
#1066
Spyre Therapeutics, Inc. - Common Stock
80.4 5 USD
-0.06%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-6.34%
Variazione Mensile
-11.42%
Variazione di 6 mesi
+18.75%
Variazione Annuale
+236.47%
Chiusura Precedente
85.9 0
Open
85.1 3
Minimo
80.4 5
Massimo
85.3 2
Financials
2022
Current report, 06 Jul 2022
Spyre Therapeutics, Inc. current report, 06 July 2022
8-K
Quarterly report, Q2 FY2022
Spyre Therapeutics, Inc. quarterly report, Q2 FY2022
10-Q
Current report, 07 Jun 2022
Spyre Therapeutics, Inc. current report, 07 June 2022
8-K
Current report, 02 Jun 2022
Spyre Therapeutics, Inc. current report, 02 June 2022
8-K
Current report, 20 May 2022
Spyre Therapeutics, Inc. current report, 20 May 2022
8-K
Current report, 05 May 2022
Spyre Therapeutics, Inc. current report, 05 May 2022
8-K
Current report, 05 May 2022
Spyre Therapeutics, Inc. current report, 05 May 2022
8-K
Current report, 12 Apr 2022
Spyre Therapeutics, Inc. current report, 12 April 2022
8-K
Quarterly report, Q1 FY2022
Spyre Therapeutics, Inc. quarterly report, Q1 FY2022
10-Q
Current report, 16 Mar 2022
Spyre Therapeutics, Inc. current report, 16 March 2022
8-K